Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han-Mo Yang

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 15, 2010
Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 statusKyung Woo Park, Jin Joo Park, Ki-Hyun Jeon, et al.
Cell Metabolism|March 11, 2014
Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytesSahmin Lee, Hyun-Chae Lee, Yoo-Wook Kwon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 28, 2004
Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid arterySeung-Jung Park, Hyo-Soo Kim, Han-Mo Yang, et al.
Korean Circulation Journal|May 18, 2026
Coronary Computed Tomographic Angiography Versus Functional Testing in Patients With Newly Diagnosed Type 2 Diabetes and Suspected Coronary Artery Disease: Real-world Evidence from the Nationwide CohortKyu-Sun Lee, Haechan Cho, Yeo Rae Moon, et al.
Cardiovascular Therapeutics|December 7, 2010
Clinical predictors of high posttreatment platelet reactivity to clopidogrel in KoreansKyung Woo Park, Jin Joo Park, Ki-Hyun Jeon, et al.
Circulation|November 18, 2020
Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS TrialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
International Journal of Cardiology|February 21, 2015
The efficacy and safety of mechanical hemodynamic support in patients undergoing high-risk percutaneous coronary intervention with or without cardiogenic shock: Bayesian approach network meta-analysis of 13 randomized controlled trialsJoo Myung Lee, Jonghanne Park, Jeehoon Kang, et al.
Circulation. Cardiovascular Interventions|April 20, 2021
Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers: Analysis of Data From the KAMIR-NIH RegistryChan Soon Park, Han-Mo Yang, You-Jeong Ki, et al.
Biomaterials|December 27, 2012
Highly angiogenic CXCR4(+)CD31(+) monocyte subset derived from 3D culture of human peripheral bloodJin Hur, Jae-Il Choi, Ji-Yeon Yun, et al.
Lancet (London, England)|September 4, 2020
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Arteriosclerosis, Thrombosis, and Vascular Biology|December 15, 2010
Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 statusKyung Woo Park, Jin Joo Park, Ki-Hyun Jeon, et al.
Cell Metabolism|March 11, 2014
Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytesSahmin Lee, Hyun-Chae Lee, Yoo-Wook Kwon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 28, 2004
Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid arterySeung-Jung Park, Hyo-Soo Kim, Han-Mo Yang, et al.
Korean Circulation Journal|May 18, 2026
Coronary Computed Tomographic Angiography Versus Functional Testing in Patients With Newly Diagnosed Type 2 Diabetes and Suspected Coronary Artery Disease: Real-world Evidence from the Nationwide CohortKyu-Sun Lee, Haechan Cho, Yeo Rae Moon, et al.
Cardiovascular Therapeutics|December 7, 2010
Clinical predictors of high posttreatment platelet reactivity to clopidogrel in KoreansKyung Woo Park, Jin Joo Park, Ki-Hyun Jeon, et al.
Circulation|November 18, 2020
Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS TrialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
International Journal of Cardiology|February 21, 2015
The efficacy and safety of mechanical hemodynamic support in patients undergoing high-risk percutaneous coronary intervention with or without cardiogenic shock: Bayesian approach network meta-analysis of 13 randomized controlled trialsJoo Myung Lee, Jonghanne Park, Jeehoon Kang, et al.
Circulation. Cardiovascular Interventions|April 20, 2021
Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers: Analysis of Data From the KAMIR-NIH RegistryChan Soon Park, Han-Mo Yang, You-Jeong Ki, et al.
Biomaterials|December 27, 2012
Highly angiogenic CXCR4(+)CD31(+) monocyte subset derived from 3D culture of human peripheral bloodJin Hur, Jae-Il Choi, Ji-Yeon Yun, et al.
Lancet (London, England)|September 4, 2020
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
Pageof 20